Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy-Reference-Cited by-同舟云学术

Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy

Published:2010-06 Issue:6 Volume:21 Page:1163-1167
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kodaira M.,Takahashi S.,Yamada S.,Ueda K.,Mishima Y.,Takeuchi K.,Yamamoto N.,Ishikawa Y.,Yokoyama M.,Saotome T.,Terui Y.,Hatake K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/6/1163/449850/mdp583.pdf

Reference24 articles.

1. Cancer of unknown primary origin;Briasoulis;Oncologist,1997

2. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992;Van de Wouw;Eur J Cancer,2002

3. Treatment of patients with cancer of an unknown primary site;Hainsworth;N Engl J Med,1993

4. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study;Briasoulis;J Clin Oncol,2000

5. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study;Pentheroudakis;Acta Oncol,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intervention for impending pathological fractures at proximal femur is associated with lower mortality rates in patients with intermediate-to-high risk according to the Katagiri-New score;2024-07-12

2. Cancer of Unknown Primary: When Imaging, Pathology, and Molecular Biology Do Not Match;Case Reports in Oncology;2024-06-27

3. A case of pelvic squamous cell carcinoma of unknown primary origin that responded well to radiotherapy and nivolumab;Radiology Case Reports;2024-05

4. A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy;Frontiers in Oncology;2021-05-26

5. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group;Clinical Cancer Research;2021-02-09